Psoriasis: epidemiology, clinical features, and quality of life
- PMID: 15708928
- PMCID: PMC1766861
- DOI: 10.1136/ard.2004.033217
Psoriasis: epidemiology, clinical features, and quality of life
Abstract
Psoriasis is a common chronic, recurrent, immune mediated disease of the skin and joints. It can have a significant negative impact on the physical, emotional, and, psychosocial wellbeing of affected patients. Psoriasis is found worldwide but the prevalence varies among different ethnic groups. It has a strong genetic component but environmental factors such as infections can play an important role in the presentation of disease. There are several clinical cutaneous manifestations of psoriasis but most commonly the disease presents as chronic, symmetrical, erythematous, scaling papules and plaques. The epidemiology, clinical features, and impact on quality of life of psoriasis are reviewed.
Figures





Similar articles
-
The impact of psoriasis on quality of life.Br J Dermatol. 2001 Apr;144 Suppl 58:33-6. doi: 10.1046/j.1365-2133.2001.144s58033.x. Br J Dermatol. 2001. PMID: 11501512 Review.
-
Psychodermatological mechanisms of psoriasis.Dermatol Ther. 2020 Nov;33(6):e13827. doi: 10.1111/dth.13827. Epub 2020 Jul 6. Dermatol Ther. 2020. PMID: 32543743 Review.
-
The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.Dermatology. 2019;235(4):308-314. doi: 10.1159/000496604. Epub 2019 May 23. Dermatology. 2019. PMID: 31121589
-
Stress and quality of life in psoriasis: an update.Int J Dermatol. 2011 Jul;50(7):783-92. doi: 10.1111/j.1365-4632.2010.04844.x. Int J Dermatol. 2011. PMID: 21699511 Review.
-
Clinical presentation of psoriasis.Reumatismo. 2007;59 Suppl 1:40-5. Reumatismo. 2007. PMID: 17828342
Cited by
-
Application of the dermatology life quality index in clinical trials of biologics for psoriasis.Chin J Integr Med. 2012 Mar;18(3):179-85. doi: 10.1007/s11655-012-1007-0. Epub 2012 Apr 2. Chin J Integr Med. 2012. PMID: 22466941 Review.
-
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis.Dermatol Ther (Heidelb). 2020 Dec;10(6):1383-1396. doi: 10.1007/s13555-020-00454-z. Epub 2020 Oct 13. Dermatol Ther (Heidelb). 2020. PMID: 33048333 Free PMC article.
-
Comparison of Behavioral Risk Factors and Cardiometabolic Comorbidities of Psoriatic Arthritis and Psoriasis: A Case-Control Study in Chinese Patients.Ther Clin Risk Manag. 2021 May 3;17:397-404. doi: 10.2147/TCRM.S307102. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 33976548 Free PMC article.
-
Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis.Dermatol Ther (Heidelb). 2022 Nov;12(11):2589-2600. doi: 10.1007/s13555-022-00824-9. Epub 2022 Oct 12. Dermatol Ther (Heidelb). 2022. PMID: 36223060 Free PMC article.
-
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab.Clin Cosmet Investig Dermatol. 2023 Dec 5;16:3503-3507. doi: 10.2147/CCID.S447123. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 38077922 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical